Saturday February 16, 2019
Home India Private hospi...

Private hospitals deny access: Dengue claims son, Parents commit suicide

0
//
source: www.cafleurebon.com

dengueBy Newsgram Staff Writer

New Delhi: Lakshman Chandra Raut (35) and Babita Raut (30) committed suicide by jumping from the fourth floor of a building when their seven-year-old son Avinash Raut died of dengue, said Delhi Police on Saturday.

Police said the couple hailing from Odisha jumped from their rented accommodation in the Lado Sarai area of south Delhi on Wednesday around 12.15 am. The parents have left a suicide note in Odia explaining that they were responsible for their own actions.

A suicide note was also recovered from the possession of the couple in which it was mentioned that they were in extreme shock over the death of their son. The note was written in Odia. The couple also mentioned that nobody is responsible for their act and that they were responsible for their decision,” the officer said.

After being diagnosed with the symptoms of dengue, Avinash was denied admission in five private hospitals, police said. He was finally admitted on September 4 but died during treatment on September 8, unable to make up for the lost time.

The Delhi government has issued a show-cause notice to these hospitals.

Moolchand Khairati Ram Hospital, Aakash Hospital, Saket City Hospital, Max Hospital (Saket) and Irene Hospital (Kalkaji) have been asked to reply in a month as to why their registration should not be cancelled for refusing emergency medical care to the deceased child,” said a Delhi government official.

While Health Minister Satyendra Jain promised stringent steps to be taken in the case, the Union Health Minister J.P. Nadda went a step further: “I have ordered an inquiry into the incident reported in the media involving the death of a child in Delhi due to dengue and the suicide by his parents. Guilty won’t be spared.”

The Central government is  also probing into the matter.

(With inputs from IANS)

 

Next Story

20 Genes That Can Predict Severity of Dengue Identified

The genes could serve as a basis for a targeted therapy for dengue, Einav said - but that's far on the horizon

0
www.nbcmiami.com

Researchers, including one of an Indian-origin, have identified 20 genes that can predict an individual’s likelihood of developing a severe form of dengue fever with about 80 per cent accuracy.

The team from Standford University in the US, identified a gene-expression pattern that predicts which people infected with dengue — a mosquito-borne virus that can cause fever and joint pain, among other symptoms — are at highest risk for developing a severe form of the illness.

Every year, between 200 million and 400 million people in tropical and subtropical regions of the world contract dengue fever, and about 500,000 of those cases are fatal.

For the most part, people with the disease recover after receiving some fluids and a few days’ rest, said Purvesh Khatri, Associate Professor at the varsity.

“But there’s a smaller subset of patients who get severe dengue, and right now we don’t know how to tell the difference,” Khatri said.

Aedes
Dengue is transmitted by the bite of the Aedes mosquito that typically attacks during day time. Pixabay

Anywhere from 5 to 20 per cent of dengue cases will advance to severe.

Currently, to diagnose severe dengue the doctors wait to observe specific symptoms and results of laboratory tests that typically emerge in the late stages of the disease.

“These practices are not nearly sensitive or accurate enough, and some patients end up admitted to the hospital unnecessarily, while others are discharged prematurely,” said Shirit Einav, Associate Professor.

Also Read- FSSAI Bans Use of Staple Pins in Tea Bags

The new set of genes, reported in the Cell Reports journal, can help identify predictive biomarkers that can help doctors reliably gauge the likelihood of severe dengue in patients who are newly symptomatic and use that information to provide more accurate care to help guide therapeutic clinical studies and, in the future, to guide treatment decisions.

The genes could serve as a basis for a targeted therapy for dengue, Einav said – but that’s far on the horizon. (IANS)